Late Breaking Abstract - Peripheral T-cells and their cytokine production in Chronic Thromboembolic Pulmonary Hypertension.

D. Van Uden (Rotterdam, Netherlands), T. Koudstaal (Rotterdam, Netherlands), J. Van Hulst (Rotterdam, Netherlands), M. Vink (Rotterdam, Netherlands), M. Van Nimwegen (Rotterdam, Netherlands), P. Heukels (Rotterdam, Netherlands), A. Van Den Bosch (Rotterdam, Netherlands), M. Kool (Rotterdam, Netherlands), R. Hendriks (Rotterdam, Netherlands), K. Boomars (Rotterdam, Netherlands)

Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Session: Non-pulmonary arterial hypertension pulmonary hypertension
Session type: Oral Presentation
Number: 180

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Van Uden (Rotterdam, Netherlands), T. Koudstaal (Rotterdam, Netherlands), J. Van Hulst (Rotterdam, Netherlands), M. Vink (Rotterdam, Netherlands), M. Van Nimwegen (Rotterdam, Netherlands), P. Heukels (Rotterdam, Netherlands), A. Van Den Bosch (Rotterdam, Netherlands), M. Kool (Rotterdam, Netherlands), R. Hendriks (Rotterdam, Netherlands), K. Boomars (Rotterdam, Netherlands). Late Breaking Abstract - Peripheral T-cells and their cytokine production in Chronic Thromboembolic Pulmonary Hypertension.. 180

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - High blood neutrophils are associated with increased exacerbations and mortality in Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019

Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Treatment of Chronic Thromboembolic Pulmonary Hypertension: A new approach
Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension
Year: 2018


Iron Deficiency in Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019


Interventional Treatment in Chronic Thromboembolic Pulmonary Hypertension with Microvasculopathy
Source: Virtual Congress 2020 – Pulmonary embolism and beyond
Year: 2020


Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Frequency and risk factors for Chronic Thromboembolic Pulmonary Hypertension after a first unprovoked Pulmonary Embolism: results from PADIS-studies.
Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension
Year: 2021



Chronic Thromboembolic Pulmonary Hypertension related to ICD
Source: International Congress 2018 – CC2 Broad spectrum of chronic thromboembolic pulmonary hypertension
Year: 2018


Liquid biopsy for Chronic Thromboembolic Pulmonary Hypertension: Circulating microRNA profile by Next Generation Sequencing
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Effects on Right Ventricular size and function by Riociguat in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (The RIVER Study)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

Incidence of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) at six months of a Pulmonary Embolism (PE). OSIRIS Study
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017

Late Breaking Abstract - BBT-877, a Potent Autotaxin Inhibitor in Clinical Development to Treat Idiopathic Pulmonary Fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019

Sleep Disordered Breathing (SDB) and Chronic Thromboembolic Pulmonary Hypertension: the Effects of Pulmonary Endoarterectomy
Source: International Congress 2017 – CPAP therapy
Year: 2017


Late Breaking Abstract - Long-term Effect of Pulmonary Rehabilitation under Nintedanib treatment in Idiopathic Pulmonary Fibrosis (FITNESS study)
Source: Virtual Congress 2021 – ALERT: Asthma in adult, in children and ILDs
Year: 2021



Late Breaking Abstract - Development of an animal model for group 3 Pulmonary Hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018



Th17 inflammation and pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Late Breaking Abstract - Arterial Stiffness and Cardiovascular Risk in hospitalised COPD patients
Source: International Congress 2019 – Imaging of airway diseases
Year: 2019



Chronic thromboembolic vasculopathy with exercise induced PH but normal resting haemodynamics
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Red Blood Cell Distribution Width as a potential predictor of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020